News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Sanofi-Aventis (France) Settles Further Eloxatin Patent Suits
April 6, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Sanofi-Aventis has settled a patent law suit over cancer drug Eloxatin with additional drugmakers, stopping them selling their generic versions in the United States from June 30 until August 2012.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Sanofi (France)
MORE ON THIS TOPIC
Policy
Flagship CEO Calls Out Attacks on Science, Warns of China Dominance
January 12, 2026
·
4 min read
·
Heather McKenzie
Vaccines
Vaccine Investors Keep Their Heads Down as Trump Cuts Shot Schedule
January 6, 2026
·
3 min read
·
Dan Samorodnitsky
Obesity
Roche Clears Obesity Pill Legal Concerns With Structure Patent Agreement
January 6, 2026
·
2 min read
·
Tristan Manalac
Drug pricing
Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026
January 6, 2026
·
5 min read
·
Annalee Armstrong
